Overview

Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours

Status:
Terminated

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

Summary

This is a prospective, open-label, multicenter phase IV.II study. Patients with local relapse breast cancer will receive radiotherapy concomitant to the administration of capecitabine.

Phase:

Phase 2

Details

Lead Sponsor:

Spanish Breast Cancer Research Group

Collaborator:

Hoffmann-La Roche

Treatments:

Capecitabine